Optimising Rotavirus Vaccine in Aboriginal Children (ORVAC)
The ORVAC Trial: A Phase IV, Double-blind, Randomised, Placebo-controlled Clinical Trial of a Third Scheduled Dose of RV1 Rotavirus Vaccine in Australian Indigenous Infants to Improve Protection Against Gastroenteritis
Sponsor: Menzies School of Health Research
This PHASE4 trial investigates Viral Gastroenteritis Due to Rotavirus and is currently ongoing. Menzies School of Health Research leads this study, which shows 13 recorded versions since 2018 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Active Not Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE4
-
Apr 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE4
Status: Unknown Status → Active Not Recruiting
-
Nov 2022 — Apr 2024 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jan 2021 — Nov 2022 [monthly]
Recruiting PHASE4
▶ Show 8 earlier versions
-
Dec 2020 — Jan 2021 [monthly]
Recruiting PHASE4
-
Nov 2020 — Dec 2020 [monthly]
Recruiting PHASE4
-
Sep 2019 — Nov 2020 [monthly]
Recruiting PHASE4
-
Jun 2018 — Sep 2019 [monthly]
Recruiting PHASE4
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE4
-
Apr 2018 — May 2018 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Oct 2017 — Apr 2018 [monthly]
Not Yet Recruiting PHASE4
-
Jan 2017 — Oct 2017 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Menzies School of Health Research
- Telethon Kids Institute
For direct contact, visit the study record on ClinicalTrials.gov .